Air Products & Chemicals
APD
278.12
-2.88
-1.02%
Air Products & Chemicals
US · APD
#351 by market cap
Listed 1970
278.12
-2.88
-1.02%
Live - 5344 symbols - heartbeat 66s ago
· 2026-10-08 05:06
Pre-market
275.20
-1.05%
After-hours
278.12
0.00%
Overnight
277.29
-0.30%
- Market cap
- 61.93B
- P/E (TTM)i
- -1,324.38
- P/Bi
- 4.46
- EPSi
- -1.77
- Div yieldi
- 2.59%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on APD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.74, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.52% YoY
Margins
- Gross margin
- 31.41%
- Operating margin
- 24.00%
- Net margin
- -3.28%
Key ratios & quality
- Enterprise valuei
- 77.87B
- Altman Z-Scorei
- 2.74
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.93B | 8.92B | 8.86B | 10.32B | 12.70B | 12.60B | 12.10B | 12.04B |
| Gross profit | 2.74B | 2.94B | 3.00B | 3.14B | 3.36B | 3.77B | 3.93B | 3.78B |
| Selling & admin expenses | 760.80M | 750.00M | 742.10M | 828.40M | 900.60M | 957.00M | 942.40M | 906.10M |
| Research & development | 64.50M | 72.90M | 83.90M | 93.50M | 102.90M | 105.60M | 100.20M | 96.30M |
| Operating profit | 1.97B | 2.17B | 2.24B | 2.27B | 2.41B | 2.74B | 2.95B | 2.89B |
| Pretax profit | 2.02B | 2.29B | 2.42B | 2.51B | 2.75B | 2.88B | 4.82B | -440.70M |
| Tax | 524.30M | 480.10M | 478.40M | 462.80M | 500.80M | 551.20M | 944.90M | -94.30M |
| Net profit | 1.53B | 1.81B | 1.93B | 2.11B | 2.27B | 2.34B | 3.86B | -354.40M |
| Basic EPS | 7 | 8 | 9 | 9 | 10 | 10 | 17 | -2 |
| Diluted EPS | 6.78 | 7.94 | 8.49 | 9.43 | 10.14 | 10.33 | 17.18 | -1.77 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.92B | 3.02B | 3.17B | 3.10B | 3.17B | 3.16B |
| Gross profit | 862.30M | 982.60M | 1.02B | 995.00M | 987.40M | 1.04B |
| Selling & admin expenses | 222.00M | 222.60M | 219.10M | 228.70M | 227.20M | 219.10M |
| Research & development | 22.90M | 24.10M | 27.30M | 20.40M | 21.60M | 21.50M |
| Operating profit | 631.30M | 772.40M | 811.80M | 756.50M | 752.70M | 810.30M |
| Pretax profit | -2.24B | 890.80M | 121.30M | 850.80M | 883.50M | -1.94B |
| Tax | -505.80M | 159.60M | 111.20M | 159.40M | 158.70M | -515.40M |
| Net profit | -1.74B | 723.20M | 10.10M | 691.40M | 724.80M | -1.42B |
| Basic EPS | -8 | 3 | 0 | 3 | 3 | -6 |
| Diluted EPS | -7.77 | 3.20 | 0.02 | 3.04 | 3.19 | -6.47 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.08B | 4.62B | 8.68B | 8.38B | 6.28B | 5.20B | 6.36B | 5.83B |
| Cash & ST investments | 2.98B | 2.41B | 6.36B | 5.80B | 3.30B | 1.95B | 2.98B | 1.86B |
| Inventory | 396.10M | 388.30M | 404.80M | 453.90M | 514.20M | 651.80M | 766.00M | 776.50M |
| Total assets | 19.18B | 18.94B | 25.17B | 26.86B | 27.19B | 32.00B | 39.57B | 41.06B |
| Total current liabilities | 2.34B | 1.82B | 2.42B | 2.80B | 3.47B | 3.90B | 4.18B | 4.22B |
| Short-term debt | 460.90M | 98.60M | 548.40M | 565.50M | 649.00M | 969.20M | 795.20M | 842.80M |
| Long-term debt | 3.35B | 3.23B | 7.43B | 7.15B | 7.09B | 9.43B | 13.53B | 16.95B |
| Total liabilities | 8,002,000,000.00 | 7,554,500,000.00 | 12,725,400,000.00 | 12,771,200,000.00 | 13,490,200,000.00 | 16,342,200,000.00 | 20,900,900,000.00 | 23,709,700,000.00 |
| Total equity | 11.18B | 11.39B | 12.44B | 14.09B | 13.70B | 15.66B | 18.67B | 17.35B |
| Retained earnings | 13.41B | 14.14B | 14.88B | 15.68B | 16.52B | 17.29B | 19.55B | 17.56B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.19B | 6.15B | 5.83B | 5.10B | 5.01B | 4.96B |
| Cash & ST investments | 1.60B | 2.32B | 1.86B | 1.03B | 951.00M | 980.50M |
| Inventory | 769.70M | 797.70M | 776.50M | 788.10M | 767.90M | 751.60M |
| Total assets | 38.87B | 41.66B | 41.06B | 41.24B | 41.64B | 40.45B |
| Total current liabilities | 5.21B | 4.76B | 4.22B | 3.50B | 3.51B | 4.58B |
| Short-term debt | 1.60B | 1.24B | 842.80M | 236.50M | 487.90M | 896.20M |
| Long-term debt | 14.25B | 16.46B | 16.95B | 17.30B | 17.27B | 16.77B |
| Total liabilities | 22,093,300,000.00 | 23,891,100,000.00 | 23,709,700,000.00 | 23,403,600,000.00 | 23,494,900,000.00 | 23,849,200,000.00 |
| Total equity | 16.78B | 17.77B | 17.35B | 17.84B | 18.15B | 16.60B |
| Retained earnings | 17.64B | 17.95B | 17.56B | 17.84B | 18.14B | 16.30B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.53B | 2.97B | 3.26B | 3.34B | 3.23B | 3.21B | 3.65B | 3.26B |
| Depreciation & amortization | 970.70M | 1.08B | 1.19B | 1.32B | 1.34B | 1.36B | 1.45B | 1.56B |
| Free cash flow | 966.00M | 980.20M | 755.70M | 877.70M | 303.70M | -1.42B | -3.15B | -3.77B |
| Dividends paid | -897.80M | -994.00M | -1.10B | -1.26B | -1.38B | -1.50B | -1.56B | -1.58B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 2.79B | 2.25B | 5.25B | 4.47B | 2.71B | 1.62B | 2.98B | 1.86B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 328.10M | 855.80M | 1.26B | 900.70M | 1.10B | 1.31B |
| Depreciation & amortization | 383.60M | 401.00M | 412.80M | 370.70M | 375.00M | 385.40M |
| Free cash flow | -1.56B | -640.00M | -256.50M | -350.50M | -3.90M | 309.50M |
| Dividends paid | -393.80M | -398.30M | -398.40M | -398.40M | -398.60M | -403.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.49B | 2.32B | 1.86B | 1.03B | 951.00M | 980.50M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.30 | 16.06 | 16.31 | 16.39 | 16.91 | 16.76 | 24.42 | -2.46 |
| ROA %i | 7.96 | 9.23 | 8.55 | 8.07 | 8.35 | 7.77 | 10.70 | -0.98 |
| ROIC %i | 11.10 | 12.86 | 11.36 | 10.51 | 10.92 | 10.44 | 13.95 | -0.69 |
| 5-year avg ROE %i | 17.86 | 18.32 | 18.09 | 19.60 | 16.00 | 16.49 | 18.16 | 14.40 |
| EBIT margin %i | 24.03 | 27.21 | 28.60 | 25.66 | 22.70 | 24.28 | 41.65 | -1.88 |
| FCF / sales %i | 10.90 | 10.99 | 8.53 | 8.50 | 2.39 | -- | -- | -- |
| Current ratioi | 2.17 | 2.54 | 3.59 | 2.99 | 1.81 | 1.33 | 1.52 | 1.38 |
| Quick ratioi | 1.86 | 2.10 | 3.22 | 2.66 | 1.54 | 1.06 | 1.23 | 1.00 |
| Debt / assetsi | 19.88 | 17.56 | 33.03 | 30.60 | 30.62 | 34.47 | 37.92 | 44.83 |
| LT debt / equityi | 30.87 | 29.20 | 64.29 | 56.53 | 58.41 | 70.30 | 83.41 | 116.90 |
| Interest coveragei | 16.44 | 17.71 | 23.18 | 18.68 | 22.52 | 17.24 | 23.03 | -1.06 |
| Revenue CAGR (3Y) %i | 4.51 | 5.93 | 2.65 | 4.95 | 12.50 | 12.47 | 5.44 | -1.77 |
| Net income CAGR (3Y) %i | 5.44 | 40.76 | -14.33 | 11.91 | 8.63 | 6.83 | 22.18 | -- |
| FCF CAGR (3Y) %i | -9.59 | -17.62 | 13.09 | -3.14 | -32.33 | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.35 | 10.12 | -2.46 | -2.08 | 13.89 | -0.32 |
| ROA %i | 4.10 | 3.94 | -0.98 | -0.82 | 5.23 | -0.12 |
| ROIC %i | 5.60 | 5.38 | -0.69 | -0.47 | 7.02 | 0.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.39 | 17.72 | -1.88 | -1.27 | 23.90 | 1.10 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.00 | 1.29 | 1.38 | 1.46 | 1.43 | 1.08 |
| Quick ratioi | 0.80 | 1.07 | 1.00 | 1.05 | 1.03 | 0.78 |
| Debt / assetsi | 42.43 | 44.03 | 44.83 | 43.98 | 44.08 | 44.89 |
| LT debt / equityi | 101.28 | 110.09 | 116.90 | 116.16 | 114.19 | 124.33 |
| Interest coveragei | 10.99 | 10.91 | -1.06 | -0.68 | 12.79 | 0.63 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 05:06:06 · For reference only, not investment advice and not tailored to your situation.